Skip to content

Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio

Perinatal Outcomes in Patients With Suspicion of Preeclampsia and Elevated sFlt-1/PlGF Before Term: A Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06403722
Enrollment
190
Registered
2024-05-08
Start date
2023-11-15
Completion date
2024-01-30
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension in Pregnancy

Keywords

Hypertension, pregnancy induced, Angiogenic factors

Brief summary

Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.

Interventions

DIAGNOSTIC_TESTStandard of care

No intervention. Clinical evolution was recorded, looking for perinatal complications.

Sponsors

Saint Thomas Hospital, Panama
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Diagnosis of hypertensive disorder of pregnancy * Gestational age between 24 - 36 6/7 * sFlt-1/PlGF \> 110

Exclusion criteria

* Gestational age below 23 6/7 weeks and above 37 weeks at the moment of admission. * Absence of sFLt-1/PlGF ratio result.

Design outcomes

Primary

MeasureTime frameDescription
Kidney injuryFrom the moment of admission up until discharge after delivery, average 5 to 10 daysCreatinine level \> 1.1 Doubling of creatinine levels when others causes had been excluded
Hepatic enzyme abnormalitiesFrom the moment of admission up until discharge after delivery, average 5 to 10 daysIncrease of liver enzyme to \> twice the upper limit of normal
HELLP SyndromeFrom the moment of admission up until discharge after delivery, average 5 to 10 daysElevated liver enzymes Thrombocytopenia Hemolysis
Growth restricted fetusFrom the moment of admission up until delivery, average 5 to 10 daysFetal weight below 10th percentile and abnormal doppler Fetal weight below 3th percentile
StillbirthFrom the moment of admission up until discharge after delivery, average 5 to 10 daysIntrauterine fetal demise

Countries

Panama

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026